Notes
Mepolizumab (Nucala®, GlaxoSmithKline plc.) for the Treatment of Severe Asthma with Eosinophilia: Effectiveness, Value, and Value-Based Price Benchmarks
Insulin Degludec (Tresiba®, Novo Nordisk A/S) for the Treatment of Diabetes: Effectiveness, Value, and Value-Based Price Benchmarks
Reference
Institute for Clinical and Economic Review. ICER Releases Final Reports on Drugs to Treat Diabetes and Asthma. Internet Document : 14 Mar 2016. Available from: URL: http://www.icer-review.org/icer-releases-final-reports-on-drugs-to-treat-diabetes-and-asthma/
Rights and permissions
About this article
Cite this article
ICER releases final reports on mepolizumab and insulin degludec. PharmacoEcon Outcomes News 749, 4 (2016). https://doi.org/10.1007/s40274-016-2891-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-2891-x